Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Progress toward standardized diagnosis of vascular cognitive impairment
T2 - Guidelines from the Vascular Impairment of Cognition Classification Consensus Study
AU - VICCCS group
AU - Skrobot, Olivia A.
AU - Black, Sandra E.
AU - Chen, Christopher
AU - DeCarli, Charles
AU - Erkinjuntti, Timo
AU - Ford, Gary A.
AU - Kalaria, Rajesh N.
AU - O'Brien, John
AU - Pantoni, Leonardo
AU - Pasquier, Florence
AU - Roman, Gustavo C.
AU - Wallin, Anders
AU - Sachdev, Perminder
AU - Skoog, Ingmar
AU - Taragano, F. E.
AU - Kril, J.
AU - Cavalieri, M.
AU - Jellinger, K. A.
AU - Kovacs, G. G.
AU - Engelborghs, S.
AU - Lafosse, C.
AU - Bertolucci, P. H.
AU - Brucki, S.
AU - Caramelli, P.
AU - de Toledo Ferraz Alves, T. C.
AU - Bocti, C.
AU - Fulop, T.
AU - Hogan, D. B.
AU - Hsiung, G. R.
AU - Kirk, A.
AU - Leach, L.
AU - Robillard, A.
AU - Sahlas, D. J.
AU - Guo, Q.
AU - Tian, J.
AU - Hokkanen, L.
AU - Jokinen, H.
AU - Benisty, S.
AU - Deramecourt, V.
AU - Hauw, J.
AU - Lenoir, H.
AU - Tsatali, M.
AU - Tsolaki, M.
AU - Sundar, U.
AU - Coen, R. F.
AU - Korczyn, A. D.
AU - Altieri, M.
AU - Baldereschi, M.
AU - Caltagirone, C.
AU - Kruglov, L. S.
N1 - Funding Information: G.A.F. reports personal fees from Pfizer, Athersys, AstraZeneca, Lundbeck, Cerevast, and Daiichi Sankyo, and grants and personal fees from Boehringer Ingelheim, outside the submitted work. J. O'B. reports personal fees from GE Healthcare, TauRx, and Cytox, and grants and personal fees from Avid/Lilly, outside the submitted work. I.S. reports personal fees and other from Takeda, outside the submitted work. Outside the submitted work, S.E.B. reports institutional grants from Pfizer, GE Healthcare, Eli Lilly, Elan/Transition Therapeutics, Roche, and Cognoptix, and personal fees from Pfizer, GE Healthcare, Eli Lilly, Eisai, Boehringer Ingelheim, and Novartis. Funding Information: This work was supported by a project grant (Ref117) from the Alzheimer's Society (UK). Publisher Copyright: © 2017 the Alzheimer's Association Copyright: Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/3
Y1 - 2018/3
N2 - Introduction: Progress in understanding and management of vascular cognitive impairment (VCI) has been hampered by lack of consensus on diagnosis, reflecting the use of multiple different assessment protocols. A large multinational group of clinicians and researchers participated in a two-phase Vascular Impairment of Cognition Classification Consensus Study (VICCCS) to agree on principles (VICCCS-1) and protocols (VICCCS-2) for diagnosis of VCI. We present VICCCS-2. Methods: We used VICCCS-1 principles and published diagnostic guidelines as points of reference for an online Delphi survey aimed at achieving consensus on clinical diagnosis of VCI. Results: Six survey rounds comprising 65–79 participants agreed guidelines for diagnosis of VICCCS-revised mild and major forms of VCI and endorsed the National Institute of Neurological Disorders–Canadian Stroke Network neuropsychological assessment protocols and recommendations for imaging. Discussion: The VICCCS-2 suggests standardized use of the National Institute of Neurological Disorders–Canadian Stroke Network recommendations on neuropsychological and imaging assessment for diagnosis of VCI so as to promote research collaboration.
AB - Introduction: Progress in understanding and management of vascular cognitive impairment (VCI) has been hampered by lack of consensus on diagnosis, reflecting the use of multiple different assessment protocols. A large multinational group of clinicians and researchers participated in a two-phase Vascular Impairment of Cognition Classification Consensus Study (VICCCS) to agree on principles (VICCCS-1) and protocols (VICCCS-2) for diagnosis of VCI. We present VICCCS-2. Methods: We used VICCCS-1 principles and published diagnostic guidelines as points of reference for an online Delphi survey aimed at achieving consensus on clinical diagnosis of VCI. Results: Six survey rounds comprising 65–79 participants agreed guidelines for diagnosis of VICCCS-revised mild and major forms of VCI and endorsed the National Institute of Neurological Disorders–Canadian Stroke Network neuropsychological assessment protocols and recommendations for imaging. Discussion: The VICCCS-2 suggests standardized use of the National Institute of Neurological Disorders–Canadian Stroke Network recommendations on neuropsychological and imaging assessment for diagnosis of VCI so as to promote research collaboration.
KW - consensus
KW - Criteria
KW - Delphi
KW - Guidelines
KW - Vascular cognitive impairment
KW - Vascular dementia
UR - http://www.scopus.com/inward/record.url?scp=85037059982&partnerID=8YFLogxK
U2 - 10.1016/j.jalz.2017.09.007
DO - 10.1016/j.jalz.2017.09.007
M3 - Article
C2 - 29055812
AN - SCOPUS:85037059982
VL - 14
SP - 280
EP - 292
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
SN - 1552-5260
IS - 3
ER -
ID: 37620580